Friday, January 31, 2014
Wednesday, January 15, 2014
Connections gives patients and caregivers an online meeting place where they can exchange advice, get support, and connect with the Memorial Sloan Kettering community.
Monday, January 6, 2014
Immunologist Alexander Rudensky and medical oncologist and immunologist Jedd Wolchok are investigating innovative ways to use the immune system to fight cancer.
In the Clinic
Friday, November 15, 2013
Memorial Sloan Kettering experts are leading investigations of a procedure called hyperthermic intraperitoneal chemotherapy, also known as HIPEC.
In the Clinic
Wednesday, October 23, 2013
Memorial Sloan Kettering offers patients with prostate cancer a comprehensive package of the most advanced radiation therapy approaches that enable more-personalized and effective care.
In the Community
Thursday, October 10, 2013
Memorial Sloan Kettering leads a first-of-its-kind initiative to reduce cancer and cardiovascular health disparities among South Asian immigrants in the United States.
Monday, September 16, 2013
Memorial Sloan Kettering experts discuss the impact that cancer and its treatment can have on female fertility, and options for building a family after treatment ends.
In the Lab
Friday, August 9, 2013
A Memorial Sloan Kettering study shows that an abnormal cell pattern found in the tumor tissue of some lung cancer patients may help to predict which tumors are more likely to recur after surgery.
Friday, July 12, 2013
Scott Armstrong specializes in the treatment of leukemia in children. His research focuses on the disease in children and adults.
Thursday, May 9, 2013
Dr. Lima is one of 27 biomedical researchers in the country being named an HHMI investigator today. This elite group of scientists will receive approximately $150 million over the next five years.
Thursday, March 14, 2013
Dr. Scardino discusses strategies for how physicians and patients can make the best use of PSA testing and prostate cancer treatment.
Wednesday, December 5, 2012
New, potentially practice-changing research sheds light on the long-term benefits of estrogen-blocking tamoxifen therapy in women with early-stage breast cancer whose disease is estrogen-receptor positive.
Thursday, July 5, 2012
More than 2,000 patients and their guests, caregivers, and healthcare providers attended Memorial Sloan Kettering’s cancer survivorship celebrations last month.
In the Clinic
Monday, May 21, 2012
Results of an international study indicate that the investigational drug tivozanib is more effective and better tolerated than a currently approved therapy in delaying cancer growth.
In the O.R.
Friday, March 16, 2012
Memorial Sloan Kettering is the first and only hospital in New York, New Jersey, and Connecticut to offer a new, more patient-friendly approach for doctors to precisely pinpoint and remove small breast cancers.